Optic nerve regeneration

Expert Review of Ophthalmology

Volumn 7, Issue 6, 2012, Pages 533-554

  Butt, Gibran Farook ^a   Habib, Abubakar ^a   Mahgoub, Kareem ^b   Sofela, Agbolahan ^c   Tilley, Mark ^a   Guo, Li ^a   Cordeiro, M Francesca ^a,d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b HAIRMYRES HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d WESTERN EYE HOSPITAL   (United Kingdom)

Author keywords

axonal regeneration; extrinsic; guidance; inflammation; intrinsic; nanomedicine; nerve guidance conduits; olfactory ensheathing glia; optic nerve; Schwann cell; stem cell

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 6; CALCIUM; CILIARY NEUROTROPHIC FACTOR; DLK 1 PROTEIN; EPHRIN; HISTONE ACETYLTRANSFERASE PCAF; KRUPPEL LIKE FACTOR 4; MOLECULAR SCAFFOLD; NANOPARTICLE; NETRIN; NEUROTROPHIC FACTOR; NOGO 66 RECEPTOR; PARVOVIRUS VECTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BCL 2; PROTEIN KINASE; PROTEIN NOGO; RHO KINASE; SEMAPHORIN; SLIT PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL DIFFERENTIATION; ELECTROSTIMULATION; EXTRACELLULAR MATRIX; GENE THERAPY; HUMAN; NANOMEDICINE; NANOTECHNOLOGY; NERVE DEGENERATION; NERVE FIBER REGENERATION; NERVE REGENERATION; NERVOUS SYSTEM INFLAMMATION; NEURAL STEM CELL; NEUROPROTECTION; NONHUMAN; NOTCH SIGNALING PATHWAY; OLFACTORY ENSHEATHING CELL; OPTIC NERVE; OPTIC NERVE INJURY; PLURIPOTENT STEM CELL; RETINA GANGLION CELL; REVIEW; SCHWANN CELL; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; SYNAPTOGENESIS; TRANSCORNEAL ELECTRICAL STIMULATION;

EID: 84871240475     PISSN: 17469899     EISSN: 17469902     Source Type: Journal    
DOI: 10.1586/eop.12.66     Document Type: Review

References (201)

1. Ellenberg D, Shi J, Jain S et al. Impediments to eye transplantation: ocular viability following optic-nerve transection or enucleation. Br. J. Ophthalmol. 93(9), 1134-1140 (2009).
2. Paigen K. A miracle enough: the power of mice. Nat. Med. 1(3), 215-220 (1995).
3. Murakami M, Ide C, Kanaya H. Regeneration in the rat optic nerve after cold injury. J. Neurosurg. 71(2), 254-265 (1989).
4. Ma M, Matthews BT, Lampe JW, Meaney DF, Shofer FS, Neumar RW. Immediate short-duration hypothermia provides long-term protection in an in vivo model of traumatic axonal injury. Exp. Neurol. 215(1), 119-127 (2009).
5. Dibas A, Oku H, Fukuhara M et al. Changes in ocular aquaporin expression following optic nerve crush. Mol. Vis. 16, 330-340 (2010).
6. Berkelaar M, Clarke DB, Wang YC, Bray GM, Aguayo AJ. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J. Neurosci. 14(7), 4368-4374 (1994).
7. Levkovitch-Verbin H, Quigley HA, Martin KR, Zack DJ, Pease ME, Valenta DF. A model to study differences between primary and secondary degeneration of retinal ganglion cells in rats by partial optic nerve transection. Invest. Ophthalmol. Vis. Sci. 44(8), 3388-3393 (2003).
8. Fu CT, Tran T, Sretavan D. Axonal/glial upregulation of EphB/ephrin-B signaling in mouse experimental ocular hypertension. Invest. Ophthalmol. Vis. Sci. 51(2), 991-1001 (2010).
9. Bull ND, Irvine KA, Franklin RJ, Martin KR. Transplanted oligodendrocyte precursor cells reduce neurodegeneration in a model of glaucoma. Invest. Ophthalmol. Vis. Sci. 50(9), 4244-4253 (2009).
10. Ellis-Behnke R. Nano neurology and the four P's of central nervous system regeneration: preserve, permit, promote, plasticity. Med. Clin. North Am. 91(5), 937-962 (2007).
11. Bohn RC, Stelzner DJ. The aberrant retino-retinal projection during optic nerve regeneration in the frog. III. Effects of crushing both nerves. J. Comp. Neurol. 196(4), 633-643 (1981).
12. Nash M, Pribiag H, Fournier AE, Jacobson C. Central nervous system regeneration inhibitors and their intracellular substrates. Mol. Neurobiol. 40(3), 224-235 (2009).
13. Ransohoff RM. Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology. Immunity 31(5), 711-721 (2009).
14. Luo JM, Zhi Y, Chen Q et al. Influence of macrophages and lymphocytes on the survival and axon regeneration of injured retinal ganglion cells in rats from different autoimmune backgrounds. Eur. J. Neurosci. 26(12), 3475-3485 (2007).
15. Vargas ME, Watanabe J, Singh SJ, Robinson WH, Barres BA. Endogenous antibodies promote rapid myelin clearance and effective axon regeneration after nerve injury. Proc. Natl Acad. Sci. USA 107(26), 11993-11998 (2010).
16. Ziv NE, Spira ME. Localized and transient elevations of intracellular Ca2+ induce the dedifferentiation of axonal segments into growth cones. J. Neurosci. 17(10), 3568-3579 (1997).
17. Xiong X, Wang X, Ewanek R, Bhat P, Diantonio A, Collins CA. Protein turnover of the Wallenda/DLK kinase regulates a retrograde response to axonal injury. J. Cell Biol. 191(1), 211-223 (2010).
18. Ghosh-Roy A, Wu Z, Goncharov A, Jin Y, Chisholm AD. Calcium and cyclic AMP promote axonal regeneration in Caenorhabditis elegans and require DLK-1 kinase. J. Neurosci. 30(9), 3175-3183 (2010).
19. Hammarlund M, Nix P, Hauth L, Jorgensen EM, Bastiani M. Axon regeneration requires a conserved MAP kinase pathway. Science 323(5915), 802-806 (2009).
20. Chen DF, Schneider GE, Martinou JC, Tonegawa S. Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature 385(6615), 434-439 (1997).
21. Cho KS, Chen DF. Promoting optic nerve regeneration in adult mice with pharmaceutical approach. Neurochem. Res. 33(10), 2126-2133 (2008).
22. Gaub P, Joshi Y, Wuttke A et al. The histone acetyltransferase p300 promotes intrinsic axonal regeneration. Brain 134(Pt 7), 2134-2148 (2011).
23. Chen L, Wang Z, Ghosh-Roy A et al. Axon regeneration pathways identified by systematic genetic screening in C. elegans. Neuron 71(6), 1043-1057 (2011).
24. O'Rourke SM, Christensen SN, Bowerman B. Caenorhabditis elegans EFA-6 limits microtubule growth at the cell cortex. Nat. Cell Biol. 12(12), 1235-1241 (2010).
25. Sengottuvel V, Leibinger M, Pfreimer M, Andreadaki A, Fischer D. Taxol facilitates axon regeneration in the mature CNS. J. Neurosci. 31(7), 2688-2699 (2011).
26. Park KK, Liu K, Hu Y et al. Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science 322(5903), 963-966 (2008).
27. Leibinger M, Andreadaki A, Fischer D. Role of mTOR in neuroprotection and axon regeneration after inflammatory stimulation. Neurobiol. Dis. 46(2), 314-324 (2012).
28. Bejjani RE, Hammarlund M. Notch signaling inhibits axon regeneration. Neuron 73(2), 268-278 (2012).
29. Baker BJ, Akhtar LN, Benveniste EN. SOCS1 and SOCS3 in the control of CNS immunity. Trends Immunol. 30(8), 392-400 (2009).
30. Smith PD, Sun F, Park KK et al. SOCS3 deletion promotes optic nerve regeneration in vivo. Neuron 64(5), 617-623 (2009).
31. Liu K, Tedeschi A, Park KK, He Z. Neuronal intrinsic mechanisms of axon regeneration. Annu. Rev. Neurosci. 34, 131-152 (2011).
32. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5), 861-872 (2007).
33. Moore DL, Blackmore MG, Hu Y et al. KLF family members regulate intrinsic axon regeneration ability. Science 326(5950), 298-301 (2009).
34. Wang YH, Wang DW, Wu N, Wang Y, Yin ZQ. α-Crystallin promotes rat axonal regeneration through regulation of RhoA/rock/cofilin/MLC signaling pathways. J. Mol. Neurosci. 46(1), 138-144 (2012).
35. Tokushige H, Waki M, Takayama Y, Tanihara H. Effects of Y-39983, a selective Rho-Associated protein kinase inhibitor, on blood flow in optic nerve head in rabbits and axonal regeneration of retinal ganglion cells in rats. Curr. Eye Res. 36(10), 964-970 (2011).
36. Steelman LS, Abrams SL, Whelan J et al. Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia. Leukemia 22(4), 686-707 (2008).
37. Haan C, Kreis S, Margue C, Behrmann I. Jaks and cytokine receptors -An intimate relationship. Biochem. Pharmacol. 72(11), 1538-1546 (2006).
38. Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat. Rev. Cancer 9(11), 798-809 (2009).
39. Murray PJ. The JAK-STAT signaling pathway: input and output integration. J. Immunol. 178(5), 2623-2629 (2007).
40. Ernst M, Jenkins BJ. Acquiring signalling specificity from the cytokine receptor gp130. Trends Genet. 20(1), 23-32 (2004).
41. Datta SR, Dudek H, Tao X et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91(2), 231-241 (1997).
42. Zhang S, Yu D. PI(3)king apart PTEN's role in cancer. Clin. Cancer Res. 16(17), 4325-4330 (2010).
43. Mayr B, Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. 2(8), 599-609 (2001).
44. Waltereit R, Weller M. Signaling from cAMP/PKA to MAPK and synaptic plasticity. Mol. Neurobiol. 27(1), 99-106 (2003).
45. Brunelle JK, Letai A. Control of mitochondrial apoptosis by the Bcl-2 family. J. Cell. Sci. 122(Pt 4), 437-441 (2009).
46. Tang Y, Eng C. PTEN autoregulates its expression by stabilization of p53 in a phosphatase-independent manner. Cancer Res. 66(2), 736-742 (2006).
47. Bray SJ. Notch signalling: a simple pathway becomes complex. Nat. Rev. Mol. Cell Biol. 7(9), 678-689 (2006).
48. Kim EK, Choi EJ. Pathological roles of MAPK signaling pathways in human diseases. Biochim. Biophys. Acta 1802(4), 396-405 (2010).
49. Junttila MR, Li SP, Westermarck J. Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB J. 22(4), 954-965 (2008).
50. Jaworski J. ARF6 in the nervous system. Eur. J. Cell Biol. 86(9), 513-524 (2007).
51. Amano M, Nakayama M, Kaibuchi K. Rho-kinase/ROCK: a key regulator of the cytoskeleton and cell polarity. Cytoskeleton (Hoboken). 67(9), 545-554 (2010).
52. Prinjha R, Moore SE, Vinson M et al. Inhibitor of neurite outgrowth in humans. Nature 403(6768), 383-384 (2000).
53. Wang KC, Koprivica V, Kim JA et al. Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 417(6892), 941-944 (2002).
54. Liebscher T, Schnell L, Schnell D et al. Nogo-A antibody improves regeneration and locomotion of spinal cord-injured rats. Ann. Neurol. 58(5), 706-719 (2005).
55. Freund P, Schmidlin E, Wannier T et al. Nogo-A-specific antibody treatment enhances sprouting and functional recovery after cervical lesion in adult primates. Nat. Med. 12(7), 790-792 (2006).
56. Zörner B, Schwab ME. Anti-Nogo on the go: from animal models to a clinical trial. Ann. NY Acad. Sci. 1198(Suppl. 1), E22-E34 (2010).
57. Liu BP, Cafferty WB, Budel SO, Strittmatter SM. Extracellular regulators of axonal growth in the adult central nervous system. Philos. Trans. R. Soc. Lond., B, Biol. Sci. 361(1473), 1593-1610 (2006).
58. Chivatakarn O, Kaneko S, He Z, Tessier-Lavigne M, Giger RJ. The Nogo-66 receptor NgR1 is required only for the acute growth cone-collapsing but not the chronic growth-inhibitory actions of myelin inhibitors. J. Neurosci. 27(27), 7117-7124 (2007).
59. Liu BP, Fournier A, GrandPré T, Strittmatter SM. Myelin-Associated glycoprotein as a functional ligand for the Nogo-66 receptor. Science 297(5584), 1190-1193 (2002).
60. Fischer D, He Z, Benowitz LI. Counteracting the Nogo receptor enhances optic nerve regeneration if retinal ganglion cells are in an active growth state. J. Neurosci. 24(7), 1646-1651 (2004).
61. Bertrand J, Winton MJ, Rodriguez-Hernandez N, Campenot RB, McKerracher L. Application of Rho antagonist to neuronal cell bodies promotes neurite growth in compartmented cultures and regeneration of retinal ganglion cell axons in the optic nerve of adult rats. J. Neurosci. 25(5), 1113-1121 (2005).
62. Atwal JK, Pinkston-Gosse J, Syken J et al. PirB is a functional receptor for myelin inhibitors of axonal regeneration. Science 322(5903), 967-970 (2008).
63. Winzeler AM, Mandemakers WJ, Sun MZ, Stafford M, Phillips CT, Barres BA. The lipid sulfatide is a novel myelin-Associated inhibitor of CNS axon outgrowth. J. Neurosci. 31(17), 6481-6492 (2011).
64. Silver J, Miller JH. Regeneration beyond the glial scar. Nat. Rev. Neurosci. 5(2), 146-156 (2004).
65. Galtrey CM, Fawcett JW. The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system. Brain Res. Rev. 54(1), 1-18 (2007).
66. Carulli D, Laabs T, Geller HM, Fawcett JW. Chondroitin sulfate proteoglycans in neural development and regeneration. Curr. Opin. Neurobiol. 15(1), 116-120 (2005).
67. Profyris C, Cheema SS, Zang D, Azari MF, Boyle K, Petratos S. Degenerative and regenerative mechanisms governing spinal cord injury. Neurobiol. Dis. 15(3), 415-436 (2004).
68. García-Alías G, Barkhuysen S, Buckle M, Fawcett JW. Chondroitinase ABC treatment opens a window of opportunity for task-specific rehabilitation. Nat. Neurosci. 12(9), 1145-1151 (2009).
69. Harel R, Iannotti CA, Hoh D, Clark M, Silver J, Steinmetz MP. Oncomodulin affords limited regeneration to injured sensory axons in vitro and in vivo. Exp. Neurol. 233(2), 708-716 (2012).
70. Shen Y, Tenney AP, Busch SA et al. PTPsigma is a receptor for chondroitin sulfate proteoglycan, an inhibitor of neural regeneration. Science 326(5952), 592-596 (2009).
71. Dickendesher TL, Baldwin KT, Mironova YA et al. NgR1 and NgR3 are receptors for chondroitin sulfate proteoglycans. Nat. Neurosci. 15(5), 703-712 (2012).
72. Fischer D, Pavlidis M, Thanos S. Cataractogenic lens injury prevents traumatic ganglion cell death and promotes axonal regeneration both in vivo and in culture. Invest. Ophthalmol. Vis. Sci. 41(12), 3943-3954 (2000).
73. Mansour-Robaey S, Clarke DB, Wang YC, Bray GM, Aguayo AJ. Effects of ocular injury and administration of brain-derived neurotrophic factor on survival and regrowth of axotomized retinal ganglion cells. Proc. Natl Acad. Sci. USA 91(5), 1632-1636 (1994).
74. Lorber B, Berry M, Logan A. Lens injury stimulates adult mouse retinal ganglion cell axon regeneration via both macrophageand lens-derived factors. Eur. J. Neurosci. 21(7), 2029-2034 (2005).
75. Ahmed Z, Aslam M, Lorber B, Suggate EL, Berry M, Logan A. Optic nerve and vitreal inflammation are both RGC neuroprotective but only the latter is RGC axogenic. Neurobiol. Dis. 37(2), 441-454 (2010).
76. Liu X, Hawkes E, Ishimaru T, Tran T, Sretavan DW. EphB3: an endogenous mediator of adult axonal plasticity and regrowth after CNS injury. J. Neurosci. 26(12), 3087-3101 (2006).
77. Yin Y, Henzl MT, Lorber B et al. Oncomodulin is a macrophage-derived signal for axon regeneration in retinal ganglion cells. Nat. Neurosci. 9(6), 843-852 (2006).
78. Yin Y, Cui Q, Gilbert HY et al. Oncomodulin links inflammation to optic nerve regeneration. Proc. Natl Acad. Sci. USA 106(46), 19587-19592 (2009).
79. Kurimoto T, Yin Y, Omura K et al. Long-distance axon regeneration in the mature optic nerve: contributions of oncomodulin, cAMP, and pten gene deletion. J. Neurosci. 30(46), 15654-15663 (2010).
80. Müller A, Hauk TG, Leibinger M, Marienfeld R, Fischer D. Exogenous CNTF stimulates axon regeneration of retinal ganglion cells partially via endogenous CNTF. Mol. Cell. Neurosci. 41(2), 233-246 (2009).
81. Leaver SG, Cui Q, Plant GW et al. AAV-mediated expression of CNTF promotes long-term survival and regeneration of adult rat retinal ganglion cells. Gene Ther. 13(18), 1328-1341 (2006).
82. Leibinger M, Müller A, Andreadaki A, Hauk TG, Kirsch M, Fischer D. Neuroprotective and axon growth-promoting effects following inflammatory stimulation on mature retinal ganglion cells in mice depend on ciliary neurotrophic factor and leukemia inhibitory factor. J. Neurosci. 29(45), 14334-14341 (2009).
83. Serpe CJ, Tetzlaff JE, Coers S, Sanders VM, Jones KJ. Functional recovery after facial nerve crush is delayed in severe combined immunodeficient mice. Brain Behav. Immun. 16(6), 808-812 (2002).
84. Cohen A, Bray GM, Aguayo AJ. Neurotrophin-4/5 (NT-4/5) increases adult rat retinal ganglion cell survival and neurite outgrowth in vitro. J. Neurobiol. 25(8), 953-959 (1994).
85. Leon S, Yin Y, Nguyen J, Irwin N, Benowitz LI. Lens injury stimulates axon regeneration in the mature rat optic nerve. J. Neurosci. 20(12), 4615-4626 (2000).
86. Li Y, Irwin N, Yin Y, Lanser M, Benowitz LI. Axon regeneration in goldfish and rat retinal ganglion cells: differential responsiveness to carbohydrates and cAMP. J. Neurosci. 23(21), 7830-7838 (2003).
87. Logan A, Ahmed Z, Baird A, Gonzalez AM, Berry M. Neurotrophic factor synergy is required for neuronal survival and disinhibited axon regeneration after CNS injury. Brain 129(Pt 2), 490-502 (2006).
88. Koeberle PD, Ball AK. Neurturin enhances the survival of axotomized retinal ganglion cells in vivo: combined effects with glial cell line-derived neurotrophic factor and brain-derived neurotrophic factor. Neuroscience 110(3), 555-567 (2002).
89. Pernet V, Di Polo A. Synergistic action of brain-derived neurotrophic factor and lens injury promotes retinal ganglion cell survival, but leads to optic nerve dystrophy in vivo. Brain 129(Pt 4), 1014-1026 (2006).
90. Sapieha PS, Peltier M, Rendahl KG, Manning WC, Di Polo A. Fibroblast growth factor-2 gene delivery stimulates axon growth by adult retinal ganglion cells after acute optic nerve injury. Mol. Cell. Neurosci. 24(3), 656-672 (2003).
91. Dent EW, Gupton SL, Gertler FB. The growth cone cytoskeleton in axon outgrowth and guidance. Cold Spring Harb. Perspect. Biol. 3(3), a001800.(2011).
92. Wizenmann A, Thies E, Klostermann S, Bonhoeffer F, Bähr M. Appearance of target-specific guidance information for regenerating axons after CNS lesions. Neuron 11(5), 975-983 (1993).
93. Keino-Masu K, Masu M, Hinck L et al. Deleted in Colorectal Cancer (DCC) encodes a netrin receptor. Cell 87(2), 175-185 (1996).
94. Leonardo ED, Hinck L, Masu M, Keino-Masu K, Ackerman SL, Tessier-Lavigne M. Vertebrate homologues of C. elegans UNC-5 are candidate netrin receptors. Nature 386(6627), 833-838 (1997).
95. Hong K, Hinck L, Nishiyama M, Poo MM, Tessier-Lavigne M, Stein E. A ligand-gated association between cytoplasmic domains of UNC5 and DCC family receptors converts netrin-induced growth cone attraction to repulsion. Cell 97(7), 927-941 (1999).
96. Deiner MS, Kennedy TE, Fazeli A, Serafini T, Tessier-Lavigne M, Sretavan DW. Netrin-1 and DCC mediate axon guidance locally at the optic disc: loss of function leads to optic nerve hypoplasia. Neuron 19(3), 575-589 (1997).
97. Ellezam B, Selles-Navarro I, Manitt C, Kennedy TE, McKerracher L. Expression of netrin-1 and its receptors DCC and UNC-5H2 after axotomy and during regeneration of adult rat retinal ganglion cells. Exp. Neurol. 168(1), 105-115 (2001).
98. Petrausch B, Jung M, Leppert CA, Stuermer CA. Lesion-induced regulation of netrin receptors and modification of netrin-1 expression in the retina of fish and grafted rats. Mol. Cell. Neurosci. 16(4), 350-364 (2000).
99. Ming GL, Song HJ, Berninger B, Holt CE, Tessier-Lavigne M, Poo MM. cAMPdependent growth cone guidance by netrin-1. Neuron 19(6), 1225-1235 (1997).
100. Cordeiro MF, Erskine L. Back to basics -ephrins, axonal guidance, neuroprotection and glaucoma. Br. J. Ophthalmol. 91(9), 1106 (2007).
101. Unified nomenclature for Eph family receptors and their ligands, the ephrins. Eph Nomenclature Committee. Cell 90(3), 403-404 (1997).
102. McLaughlin T, Hindges R, O'Leary DD. Regulation of axial patterning of the retina and its topographic mapping in the brain. Curr. Opin. Neurobiol. 13(1), 57-69 (2003).
103. McLaughlin T, O'Leary DD. Molecular gradients and development of retinotopic maps. Annu. Rev. Neurosci. 28, 327-355 (2005).
104. King CE, Wallace A, Rodger J, Bartlett C, Beazley LD, Dunlop SA. Transient up-regulation of retinal EphA3 and EphA5, but not ephrin-A2, coincides with re-establishment of a topographic map during optic nerve regeneration in goldfish. Exp. Neurol. 183(2), 593-599 (2003).
105. Knöll B, Isenmann S, Kilic E et al. Graded expression patterns of ephrin-As in the superior colliculus after lesion of the adult mouse optic nerve. Mech. Dev. 106(1-2), 119-127 (2001).
106. Fu CT, Sretavan D. Involvement of EphB/Ephrin-B signaling in axonal survival in mouse experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 53(1), 76-84 (2012).
107. Du J, Tran T, Fu C, Sretavan DW. Upregulation of EphB2 and ephrin-B2 at the optic nerve head of DBA/2J glaucomatous mice coincides with axon loss. Invest. Ophthalmol. Vis. Sci. 48(12), 5567-5581 (2007).
108. Duffy P, Wang X, Siegel CS et al. Myelin-derived ephrinB3 restricts axonal regeneration and recovery after adult CNS injury. Proc. Natl Acad. Sci. USA 109(13), 5063-5068 (2012).
109. Yazdani U, Terman Jr. The semaphorins. Genome Biol. 7(3), 211 (2006).
110. Giger RJ, Hollis ER 2nd, Tuszynski MH. Guidance molecules in axon regeneration. Cold Spring Harb. Perspect. Biol. 2(7), a001867 (2010).
111. Rosenzweig S, Raz-Prag D, Nitzan A et al. Sema-3A indirectly disrupts the regeneration process of goldfish optic nerve after controlled injury. Graefes Arch. Clin. Exp. Ophthalmol. 248(10), 1423-1435 (2010).
112. Shirvan A, Kimron M, Holdengreber V et al. Anti-semaphorin 3A antibodies rescue retinal ganglion cells from cell death following optic nerve axotomy. J. Biol. Chem. 277(51), 49799-49807 (2002).
113. Pasterkamp RJ, Giger RJ, Ruitenberg MJ et al. Expression of the gene encoding the chemorepellent semaphorin III is induced in the fibroblast component of neural scar tissue formed following injuries of adult but not neonatal CNS. Mol. Cell. Neurosci. 13(2), 143-166 (1999).
114. Goldberg JL, Vargas ME, Wang JT et al. An oligodendrocyte lineage-specific semaphorin, Sema5A, inhibits axon growth by retinal ganglion cells. J. Neurosci. 24(21), 4989-4999 (2004).
115. Ringstedt T, Braisted JE, Brose K et al. Slit inhibition of retinal axon growth and its role in retinal axon pathfinding and innervation patterns in the diencephalon. J. Neurosci. 20(13), 4983-4991 (2000).
116. Wyatt C, Ebert A, Reimer MM et al. Analysis of the astray/robo2 zebrafish mutant reveals that degenerating tracts do not provide strong guidance cues for regenerating optic axons. J. Neurosci. 30(41), 13838-13849 (2010).
117. Hagino S, Iseki K, Mori T et al. Slit and glypican-1 mRNAs are coexpressed in the reactive astrocytes of the injured adult brain. Glia 42(2), 130-138 (2003).
118. Schnichels S, Heiduschka P, Julien S. RGMA and neogenin protein expression are influenced by lens injury following optic nerve crush in the rat retina. Graefes Arch. Clin. Exp. Ophthalmol. 250(1), 39-50 (2012).
119. Schnichels S, Heiduschka P, Julien S. Different spatial and temporal protein expressions of repulsive guidance molecule a and neogenin in the rat optic nerve after optic nerve crush with and without lens injury. J. Neurosci. Res. 89(4), 490-505 (2011).
120. Kitayama M, Ueno M, Itakura T, Yamashita T. Activated microglia inhibit axonal growth through RGMa. PLoS ONE 6(9), e25234 (2011).
121. Tan CL, Kwok JC, Patani R, Ffrench-Constant C, Chandran S, Fawcett JW. Integrin activation promotes axon growth on inhibitory chondroitin sulfate proteoglycans by enhancing integrin signaling. J. Neurosci. 31(17), 6289-6295 (2011).
122. Moon LD, Asher RA, Rhodes KE, Fawcett JW. Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. Nat. Neurosci. 4(5), 465-466 (2001).
123. Becker CG, Becker T. Repellent guidance of regenerating optic axons by chondroitin sulfate glycosaminoglycans in zebrafish. J. Neurosci. 22(3), 842-853 (2002).
124. Condic ML. Adult neuronal regeneration induced by transgenic integrin expression. J. Neurosci. 21(13), 4782-4788 (2001).
125. Parrilla M, Lillo C, Herrero-Turrión MJ et al. Characterization of Pax2 expression in the goldfish optic nerve head during retina regeneration. PLoS ONE 7(2), e32348 (2012).
126. Rodger J, King CE, Lukehurst S et al. Changing Pax6 expression correlates with axon outgrowth and restoration of topography during optic nerve regeneration. Neuroscience 142(4), 1043-1054 (2006).
127. Sugimoto Y, Taniguchi M, Yagi T, Akagi Y, Nojyo Y, Tamamaki N. Guidance of glial precursor cell migration by secreted cues in the developing optic nerve. Development 128(17), 3321-3330 (2001).
128. Tsai HH, Miller RH. Glial cell migration directed by axon guidance cues. Trends Neurosci. 25(4), 173-5; discussion 175 (2002).
129. Williams A, Piaton G, Aigrot MS et al. Semaphorin 3A and 3F: key players in myelin repair in multiple sclerosis? Brain 130(Pt 10), 2554-2565 (2007).
130. Limb GA, Martin KR; Sixth ARVO/Pfizer Ophthalmics Research Institute Conference Working Group. Current prospects in optic nerve protection and regeneration: sixth ARVO/Pfizer Ophthalmics Research Institute conference. Invest. Ophthalmol. Vis. Sci. 52(8), 5941-5954 (2011).
131. Li N, Li XR, Yuan JQ. Effects of bonemarrow mesenchymal stem cells transplanted into vitreous cavity of rat injured by ischemia/reperfusion. Graefes Arch. Clin. Exp. Ophthalmol. 247(4), 503-514 (2009).
132. Bull ND, Irvine KA, Franklin RJ, Martin KR. Transplanted oligodendrocyte precursor cells reduce neurodegeneration in a model of glaucoma. Invest. Ophthalmol. Vis. Sci., 50(9), 4244-4253 (2009).
133. Lawrence JM, Singhal S, Bhatia B et al. MIO-M1 cells and similar muller glial cell lines derived from adult human retina exhibit neural stem cell characteristics. Stem Cells 25(8), 2033-2043 (2007).
134. Mellough CB, Cui Q, Harvey AR. Treatment of adult neural progenitor cells prior to transplantation affects graft survival and integration in a neonatal and adult rat model of selective retinal ganglion cell depletion. Restor. Neurol. Neurosci. 25(2), 177-190 (2007).
135. Aoki H, Hara A, Niwa M, Motohashi T, Suzuki T, Kunisada T. Transplantation of cells from eye-like structures differentiated from embryonic stem cells in vitro and in vivo regeneration of retinal ganglion-like cells. Graefes Arch. Clin. Exp. Ophthalmol. 246(2), 255-265 (2008).
136. Bull ND, Limb GA, Martin KR. Human Müller stem cell (MIO-M1) transplantation in a rat model of glaucoma: survival, differentiation, and integration. Invest. Ophthalmol. Vis. Sci. 49(8), 3449-3456 (2008).
137. Zwart I, Hill AJ, Al-Allaf F et al. Umbilical cord blood mesenchymal stromal cells are neuroprotective and promote regeneration in a rat optic tract model. Exp. Neurol. 216(2), 439-448 (2009).
138. Barber PC, Raisman G. Replacement of receptor neurones after section of the vomeronasal nerves in the adult mouse. Brain Res. 147(2), 297-313 (1978).
139. King-Robson J. Encouraging regeneration in the central nervous system: is there a role for olfactory ensheathing cells? Neurosci. Res. 69(4), 263-275 (2011).
140. Pellitteri R, Spatuzza M, Russo A, Zaccheo D, Stanzani S. Olfactory ensheathing cells represent an optimal substrate for hippocampal neurons: an in vitro study. Int. J. Dev. Neurosci. 27(5), 453-458 (2009).
141. Li Y, Sauvé Y, Li D, Lund RD, Raisman G. Transplanted olfactory ensheathing cells promote regeneration of cut adult rat optic nerve axons. J. Neurosci. 23(21), 7783-7788 (2003).
142. Lipson AC, Widenfalk J, Lindqvist E, Ebendal T, Olson L. Neurotrophic properties of olfactory ensheathing glia. Exp. Neurol. 180(2), 167-171 (2003).
143. Wu MM, Fan DG, Tadmori I et al. Death of axotomized retinal ganglion cells delayed after intraoptic nerve transplantation of olfactory ensheathing cells in adult rats. Cell Transplant. 19(2), 159-166 (2010).
144. Pastrana E, Moreno-Flores MT, Gurzov EN, Avila J, Wandosell F, Diaz-Nido J. Genes associated with adult axon regeneration promoted by olfactory ensheathing cells: a new role for matrix metalloproteinase 2. J. Neurosci. 26(20), 5347-5359 (2006).
145. Plant GW, Harvey AR, Leaver SG, Lee SV. Olfactory ensheathing glia: repairing injury to the mammalian visual system. Exp. Neurol. 229(1), 99-108 (2011).
146. Sandvig I, Thuen M, Hoang L et al. In vivo MRI of olfactory ensheathing cell grafts and regenerating axons in transplant mediated repair of the adult rat optic nerve. NMR Biomed. 25(4), 620-631 (2012).
147. Li Y, Li D, Raisman G. Transplanted Schwann cells, not olfactory ensheathing cells, myelinate optic nerve fibres. Glia 55(3), 312-316 (2007).
148. Leaver SG, Harvey AR, Plant GW. Adult olfactory ensheathing glia promote the long-distance growth of adult retinal ganglion cell neurites in vitro. Glia 53(5), 467-476 (2006).
149. Liu Y, Gong Z, Liu L, Sun H. Combined effect of olfactory ensheathing cell (OEC) transplantation and glial cell line-derived neurotrophic factor (GDNF) intravitreal injection on optic nerve injury in rats. Mol. Vis. 16, 2903-2910 (2010).
150. Vukovic J, Plant GW, Ruitenberg MJ, Harvey AR. Influence of adult Schwann cells and olfactory ensheathing glia on axon-target cell interactions in the CNS: a comparative analysis using a retinotectal co-graft model. Neuron Glia Biol. 3(2), 105-117 (2007).
151. Ramón-Cueto A, Muñoz-Quiles C. Clinical application of adult olfactory bulb ensheathing glia for nervous system repair. Exp. Neurol. 229(1), 181-194 (2011).
152. Mackay-Sim A, Féron F, Cochrane J et al. Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trial. Brain 131(Pt 9), 2376-2386 (2008).
153. Aguayo AJ, Bray GM, Carter DA, Villegas-Perez MP, Vidal-Sanz M, Rasminsky M. Regrowth and connectivity of injured central nervous system axons in adult rodents. Acta Neurobiol. Exp. (Wars). 50(4-5), 381-389 (1990).
154. Parrinello S, Napoli I, Ribeiro S et al. EphB signaling directs peripheral nerve regeneration through Sox2-dependent Schwann cell sorting. Cell 143(1), 145-155 (2010).
155. Vidal-Sanz M, Bray GM, Villegas-Pérez MP, Thanos S, Aguayo AJ. Axonal regeneration and synapse formation in the superior colliculus by retinal ganglion cells in the adult rat. J. Neurosci. 7(9), 2894-2909 (1987).
156. Keirstead SA, Rasminsky M, Fukuda Y, Carter DA, Aguayo AJ, Vidal-Sanz M. Electrophysiologic responses in hamster superior colliculus evoked by regenerating retinal axons. Science 246(4927), 255-257 (1989).
157. Ahmed Z, Suggate EL, Brown ER et al. Schwann cell-derived factor-induced modulation of the NgR/p75NTR/EGFR axis disinhibits axon growth through CNS myelin in vivo and in vitro. Brain 129(Pt 6), 1517-1533 (2006).
158. Hu Y, Arulpragasam A, Plant GW, Hendriks WT, Cui Q, Harvey AR. The importance of transgene and cell type on the regeneration of adult retinal ganglion cell axons within reconstituted bridging grafts. Exp. Neurol. 207(2), 314-328 (2007).
159. Hu Y, Leaver SG, Plant GW et al. Lentiviral-mediated transfer of CNTF to schwann cells within reconstructed peripheral nerve grafts enhances adult retinal ganglion cell survival and axonal regeneration. Mol. Ther. 11(6), 906-915 (2005).
160. Negishi H, Dezawa M, Oshitari T, Adachi-Usami E. Optic nerve regeneration within artificial Schwann cell graft in the adult rat. Brain Res. Bull. 55(3), 409-419 (2001).
161. Fang Y, Mo X, Guo W et al. A new type of Schwann cell graft transplantation to promote optic nerve regeneration in adult rats. J. Tissue Eng. Regen. Med. 4(8), 581-589 (2010).
162. Li S, Hu B, Tay D, So KF, Yip HK. Intravitreal transplants of Schwann cells and fibroblasts promote the survival of axotomized retinal ganglion cells in rats. Brain Res. 1029(1), 56-64 (2004).
163. Maffei L, Carmignoto G, Perry VH, Candeo P, Ferrari G. Schwann cells promote the survival of rat retinal ganglion cells after optic nerve section. Proc. Natl Acad. Sci. USA 87(5), 1855-1859 (1990).
164. Cordeiro MF, Guo L, Coxon KM et al. Imaging multiple phases of neurodegeneration: a novel approach to assessing cell death in vivo. Cell Death Dis. 1, e3 (2010).
165. Cordeiro MF, Guo L, Luong V et al. Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration. Proc. Natl Acad. Sci. USA 101(36), 13352-13356 (2004).
166. Guo L, Salt TE, Luong V et al. Targeting amyloid-β in glaucoma treatment. Proc. Natl Acad. Sci. USA 104(33), 13444-13449 (2007).
167. Plant GW, Harvey AR. A new type of biocompatible bridging structure supports axon regrowth after implantation into the lesioned rat optic tract. Cell Transplant. 9(6), 759-772 (2000).
168. Cui Q, Pollett MA, Symons NA, Plant GW, Harvey AR. A new approach to CNS repair using chimeric peripheral nerve grafts. J. Neurotrauma 20(1), 17-31 (2003).
169. Xu G, Nie DY, Wang WZ et al. Optic nerve regeneration in polyglycolic acid-chitosan conduits coated with recombinant L1-Fc. Neuroreport 15(14), 2167-2172 (2004).
170. Gu Y, Wang J, Ding F, Hu N, Wang Y, Gu X. Neurotrophic actions of bone marrow stromal cells on primary culture of dorsal root ganglion tissues and neurons. J. Mol. Neurosci. 40(3), 332-341 (2010).
171. Bhang SH, Lim JS, Choi CY, Kwon YK, Kim BS. The behavior of neural stem cells on biodegradable synthetic polymers. J. Biomater. Sci. Polym. Ed. 18(2), 223-239 (2007).
172. Alto LT, Havton LA, Conner JM, Hollis ER 2nd, Blesch A, Tuszynski MH. Chemotropic guidance facilitates axonal regeneration and synapse formation after spinal cord injury. Nat. Neurosci. 12(9), 1106-1113 (2009).
173. Gros T, Sakamoto JS, Blesch A, Havton LA, Tuszynski MH. Regeneration of long-tract axons through sites of spinal cord injury using templated agarose scaffolds. Biomaterials 31(26), 6719-6729 (2010).
174. Fischer D, Petkova V, Thanos S, Benowitz LI. Switching mature retinal ganglion cells to a robust growth state in vivo: gene expression and synergy with RhoA inactivation. J. Neurosci. 24(40), 8726-8740 (2004).
175. Lorber B, Howe ML, Benowitz LI, Irwin N. Mst3b, an Ste20-like kinase, regulates axon regeneration in mature CNS and PNS pathways. Nat. Neurosci. 12(11), 1407-1414 (2009).
176. Petrausch B, Tabibiazar R, Roser T et al. A purine-sensitive pathway regulates multiple genes involved in axon regeneration in goldfish retinal ganglion cells. J. Neurosci. 20(21), 8031-8041 (2000).
177. Wu MM, You SW, Hou B, Jiao XY, Li YY, Ju G. Effects of inosine on axonal regeneration of axotomized retinal ganglion cells in adult rats. Neurosci. Lett. 341(1), 84-86 (2003).
178. Harvey AR, Hu Y, Leaver SG et al. Gene therapy and transplantation in CNS repair: the visual system. Prog. Retin. Eye Res. 25(5), 449-489 (2006).
179. Hellström M, Muhling J, Ehlert EM et al. Negative impact of rAAV2 mediated expression of SOCS3 on the regeneration of adult retinal ganglion cell axons. Mol. Cell. Neurosci. 46(2), 507-515 (2011).
180. Hellström M, Pollett MA, Harvey AR. Post-injury delivery of rAAV2-CNTF combined with short-term pharmacotherapy is neuroprotective and promotes extensive axonal regeneration after optic nerve trauma. J. Neurotrauma 28(12), 2475-2483 (2011).
181. Rodger J, Drummond ES, Hellström M, Robertson D, Harvey AR. Long-term gene therapy causes transgene-specific changes in the morphology of regenerating retinal ganglion cells. PLoS ONE 7(2), e31061 (2012).
182. Lemmon V, Burden SM, Payne HR, Elmslie GJ, Hlavin ML. Neurite growth on different substrates: permissive versus instructive influences and the role of adhesive strength. J. Neurosci. 12(3), 818-826 (1992).
183. Roonprapunt C, Huang W, Grill R et al. Soluble cell adhesion molecule L1-Fc promotes locomotor recovery in rats after spinal cord injury. J. Neurotrauma 20(9), 871-882 (2003).
184. Ellis-Behnke RG, Liang YX, You SW et al. Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. Proc. Natl Acad. Sci. USA 103(13), 5054-5059 (2006).
185. Liang YX, Cheung SW, Chan KC, Wu EX, Tay DK, Ellis-Behnke RG. CNS regeneration after chronic injury using a self-Assembled nanomaterial and MEMRI for real-time in vivo monitoring. Nanomedicine 7(3), 351-359 (2011).
186. Crapo PM, Medberry CJ, Reing JE et al. Biologic scaffolds composed of central nervous system extracellular matrix. Biomaterials 33(13), 3539-3547 (2012).
187. GhoshMitra S, Diercks DR, Mills NC, Hynds DL, Ghosh S. Role of engineered nanocarriers for axon regeneration and guidance: current status and future trends. Adv. Drug Deliv. Rev. 64(1), 110-125 (2012).
188. Bertram JP, Saluja SS, McKain J, Lavik EB. Sustained delivery of timolol maleate from poly(lactic-co-glycolic acid)/poly(lactic acid) microspheres for over 3 months. J. Microencapsul. 26(1), 18-26 (2009).
189. Prow TW, Bhutto I, Kim SY et al. Ocular nanoparticle toxicity and transfection of the retina and retinal pigment epithelium. Nanomedicine 4(4), 340-349 (2008).
190. Harrison J, Bartlett CA, Cowin G et al. In vivo imaging and biodistribution of multimodal polymeric nanoparticles delivered to the optic nerve. Small 8(10), 1579-1589 (2012).
191. Robinson R, Viviano SR, Criscione JM et al. Nanospheres delivering the EGFR TKI AG1478 promote optic nerve regeneration: the role of size for intraocular drug delivery. ACS Nano 5(6), 4392-4400 (2011).
192. Dor H. Beiträge zur Electrotherapie der Augenkrankheiten. ArchKlin. Exp. Ophthalmol. 19(3), 316-352 (1873).
193. Fujikado T, Morimoto T, Matsushita K, Shimojo H, Okawa Y, Tano Y. Effect of transcorneal electrical stimulation in patients with nonarteritic ischemic optic neuropathy or traumatic optic neuropathy. Jpn. J. Ophthalmol. 50(3), 266-273 (2006).
194. Inomata K, Shinoda K, Ohde H et al. Transcorneal electrical stimulation of retina to treat longstanding retinal artery occlusion. Graefes Arch. Clin. Exp. Ophthalmol. 245(12), 1773-1780 (2007).
195. Schatz A, Röck T, Naycheva L et al. Transcorneal electrical stimulation for patients with retinitis pigmentosa: a prospective, randomized, sham-controlled exploratory study. Invest. Ophthalmol. Vis. Sci. 52(7), 4485-4496 (2011).
196. Gekeler F, Bartz-Schmidt KU. Electrical stimulation-A therapeutic strategy for retinal and optic nerve disease? Graefes Arch. Clin. Exp. Ophthalmol. 250(2), 161-163 (2012).
197. Tagami Y, Kurimoto T, Miyoshi T, Morimoto T, Sawai H, Mimura O. Axonal regeneration induced by repetitive electrical stimulation of crushed optic nerve in adult rats. Jpn. J. Ophthalmol. 53(3), 257-266 (2009).
198. Gall C, Fedorov AB, Ernst L, Borrmann A, Sabel BA. Repetitive transorbital alternating current stimulation in optic neuropathy. NeuroRehabilitation 27(4), 335-341 (2010).
199. Fedorov A, Jobke S, Bersnev V et al. Restoration of vision after optic nerve lesions with noninvasive transorbital alternating current stimulation: a clinical observational study. Brain Stimul. 4(4), 189-201 (2011).
200. Krick K, Tammia M, Martin R, Hoke A, Mao HQ. Signaling cue presentation and cell delivery to promote nerve regeneration. Curr. Opin. Biotechnol. 22(5), 741-746 (2011).
201. Safety of urate elevation in Parkinson's disease (SURE-PD) trial. www.clinicaltrials.gov/ct2/show/NCT008 33690?term=inosine&rank=1